Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Circulating Extracellular Vesicles Plus Glucocorticoid for Total-Type Sudden Sensorineural Hearing Loss
NCT07878559Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
Phase 3, randomised trial in sudden sensorineural hearing loss (SSHL) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Proportion of subjects whose pure-tone average (PTA) hearing threshold improved by >10 dB at 1 month. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07878559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878559.